Editorial
Copyright ©2013 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Jul 14, 2013; 19(26): 4099-4105
Published online Jul 14, 2013. doi: 10.3748/wjg.v19.i26.4099
Cellular and molecular basis of chronic constipation: Taking the functional/idiopathic label out
Gabrio Bassotti, Vincenzo Villanacci, Dragos Creƫoiu, Sanda Maria Creƫoiu, Gabriel Becheanu
Gabrio Bassotti, Gastroenterology and Hepatology Section, Department of Clinical and Experimental Medicine, University of Perugia, 06156 Perugia, Italy
Vincenzo Villanacci, Second Pathology Section, Spedali Civili, 25100 Brescia, Italy
Dragos Creƫoiu, Division of Cellular and Molecular Medicine, Department of Morphological Sciences, “Carol Davila” University of Medicine and Pharmacy, 050474 Bucharest, Romania
Dragos Creƫoiu, Department of Molecular Medicine, “Victor Babeş” National Institute of Pathology, 050474 Bucharest, Romania
Sanda Maria Creƫoiu, Division of Cellular and Molecular Medicine, Department of Morphological Sciences, “Carol Davila” University of Medicine and Pharmacy, 050474 Bucharest, Romania
Sanda Maria Creƫoiu, Department of Ultrastructural Pathology, “Victor Babeş” National Institute of Pathology, 050474 Bucharest, Romania
Gabriel Becheanu, Department of Gastroenterology and Hepatology, Fundeni Clinical Institute, 050474 Bucharest, Romania
Author contributions: Bassotti G ideated the project and wrote the first draft; Villanacci V, Creƫoiu D, Creƫoiu SM and Becheanu G critically reviewed the manuscript for important intellectual content; all authors approved the final draft of the manuscript.
Correspondence to: Gabrio Bassotti, Professor, Gastroenterology and Hepatology Section, Department of Clinical and Experimental Medicine, University of Perugia, Ospedale Santa Maria della Misericordia, Piazzale Menghini 1, 06156 Perugia, Italy. gabassot@tin.it
Telephone: +39-75-5784423 Fax: +39-75-5847570
Received: December 6, 2012
Revised: May 16, 2013
Accepted: May 18, 2013
Published online: July 14, 2013

Abstract

In recent years, the improvement of technology and the increase in knowledge have shifted several strongly held paradigms. This is particularly true in gastroenterology, and specifically in the field of the so-called “functional” or “idiopathic” disease, where conditions thought for decades to be based mainly on alterations of visceral perception or aberrant psychosomatic mechanisms have, in fact, be reconducted to an organic basis (or, at the very least, have shown one or more demonstrable abnormalities). This is particularly true, for instance, for irritable bowel syndrome, the prototype entity of “functional” gastrointestinal disorders, where low-grade inflammation of both mucosa and myenteric plexus has been repeatedly demonstrated. Thus, researchers have also investigated other functional/idiopathic gastrointestinal disorders, and found that some organic ground is present, such as abnormal neurotransmission and myenteric plexitis in esophageal achalasia and mucosal immune activation and mild eosinophilia in functional dyspepsia. Here we show evidence, based on our own and other authors’ work, that chronic constipation has several abnormalities reconductable to alterations in the enteric nervous system, abnormalities mainly characterized by a constant decrease of enteric glial cells and interstitial cells of Cajal (and, sometimes, of enteric neurons). Thus, we feel that (at least some forms of) chronic constipation should no more be considered as a functional/idiopathic gastrointestinal disorder, but instead as a true enteric neuropathic abnormality.

Key Words: Constipation, Enteric glia, Enteric nervous system, Enteric neurons, Interstitial cells of Cajap, Neurogastroenterology

Core tip: Concerning gut motility, in the last years the basic/clinical interplay between gastroenterology and neurology has become stricter, and many pathologic conditions, among which constipation, related to abnormal gastrointestinal motility are now considered and studied by a neurogastroenterological point of view. However, the fact that these conditions are still labelled as “functional” or “idiopathic” is puzzling. We examined the evidence for taking these labels out from constipation, that should be considered as a true neurenteric dysfunction.



INTRODUCTION

The field of gastrointestinal motor activity has always attracted the researchers’ interest; however, in the time course it became apparent that most gut motor disorders are attributable to disordered neural control mechanisms. Thus, by the encounter of gastroenterologists and neurologists a common branch emerged, i.e., neurogastroenterology[1], in which an equal partnership had been recognized concerning gut motility. Recently, ultrastructural morphologists joined and try to bring innovative perceptions on control mechanisms of digestive motility. This had led to interesting and exciting new perspectives in the pathophysiology of some frequent disorders, such as constipation.

Chronic constipation is a frequent symptom in the general population, where is present in 2%-30% of subjects[2]. However, apart from secondary forms, associated to an underlying disease (e.g., neurological[3,4]), commonly used (at least for scientific purposes) classifications still label most cases of constipation as “idiopathic” or “functional”[5-9].

It is worth noting that the concept of functional diseases has been somewhat questioned in the last years[10], since several studies conducted on prototypic functional entities, such as irritable bowel syndrome (IBS) and functional dyspepsia (FD) have revealed that these condition may actually harbor an organic basis[11,12]. In fact, inflammation and neuronal degeneration have been reported in IBS patients[13] and duodenal mastocytosis, eosinophilia and intraepithelial lymphocytosis have been described in both IBS and FD patients[14].

Chronic constipation may be subdivided in two main subtypes, obstructed defecation (OD) and slow transit constipation (STC), that may also co-exist in the same patient[15,16], and it is generally thought (by data originating from both experimental animal models and humans) that colonic sensorimotor dysfunction and abnormal motility play a pivotal pathogenetic role[17-19]. Thus, abnormal colonic and anorectal function had been repeatedly demonstrated in these patients[20-22], and pharmacologic stimulation may help in addressing more targeted therapeutic approaches[23,24]. However, etiological factors are still poorly known[25].

This article will deal with the available evidence for neurobiological abnormalities in chronic constipation, that suggests how this symptom often underlie a true organic enteric disorder.

NEUROENTERIC ABNORMALITIES IN CONSTIPATION

To date, there is mounting evidence that colonic neuromuscular abnormalities may be of paramount importance in this setting[26,27], and there are numerous studies showing that (at least) severely constipated patients may have one or more abnormal features mainly (although not exclusively) linked to elements of the enteric nervous system (ENS)[28].

The ENS, considered as the brain of the gut, integrates secretion and motility into homeostatic patterns of behavior susceptible to disorder[29]. Thus, it is not surprising that some of the enteric circuitries responsible for these activities may be involved in the dysfunction of their basic control mechanisms. The resulting abnormalities are summarized below.

Abnormal colonic neurochemistry

This has been repeatedly shown in constipated patients: several studies showed a decreased content of vasoactive intestinal peptide (VIP) and substance P in tissues obtained from these subjects[30-34]. Moreover, in vitro studies confirmed that the diminished contractile response to these substances plays an important role in the impaired motility observed in the colon of constipated patients[35,36]. Of note, these abnormalities seem not to be related to chronic laxative use, since anthranoids cause a reduction in the levels of inhibitory neurotransmitters (VIP, somatostatin), but not of substance P, in the rat colon[37]. Other studies showed that excitatory nerve fibres are present in the circular muscle in STC but they are deficient in tachykinins and enkephalin[38-40]. In addition, investigations conducted on colonic strips showed that a decrease of cholinergic innervation and an increase of non-adrenergic non-cholinergic (NANC) inhibitory innervation play an important role in the impaired motility observed in the colon of patients with slow transit constipation[41]; these effects are mediated by an increase of nitric oxide and a decrease of neurotensin[42-44], as also confirmed by immunohistochemical methods in surgically resected specimens[45].

Enteric nervous system

Earlier studies addressing the ENS have shown the presence of several heterogeneous abnormalities in patients with severe constipation (especially those with STC), including reduced number of argyrophilic neurons[46] and of intraganglionic neurofilaments[47], myenteric plexus hypoganglionosis[48]. More recent studies, with the increasing use of immunohistochemical techniques[49,50], have demonstrated more consistent findings on the main elements of the ENS, such as the decrease of interstitial cells of Cajal (ICC)[51,52] (up to their complete absence in colonic inertia[53]), often associated to a reduced number of enteric neurons[54,55] and/or of enteric glial cells (EGC)[56,57]. Of interest, the expression of c-kit mRNA and c-kit protein was also found to be significantly decreased in the colon of severely constipated patients, suggesting that the c-kit signal pathway may play an important role in ICC reduction in these patients[58].

Colonic smooth muscle

Only a few studies have addressed this issue, often with discordant findings, probably due to the heterogeneous cohorts of patients evaluated. Some authors reported that the ratio of the thickness of circular to longitudinal muscle was significantly lower in the left colon in constipated subjects[59], whereas other authors described a decreased circular muscle layer thickness in constipated patients[60], but no abnormalities of the colonic muscular layers were described in both studies. Another investigation showed the presence of amphophilic inclusion bodies in the muscularis externa of STC patients[61], even though these findings were found in about half of the patients. Normal actin expression was found in both adults and children with severe constipation[56,62], whereas the use of novel and nonconventional smooth muscle markers may reveal abnormalities linked to the smooth muscle contractile apparatus unnoticed by both routine stainings and alpha-actin, suggesting specific defects of smooth muscle cells involved in the pathogenesis of gastrointestinal motility disorders[63].

SIGNIFICANCE OF NEUROENTERIC ABNORMALITIES IN CONSTIPATION

There are few doubts that the ENS abnormalities repeatedly found in constipated patients play a pivotal role in the genesis of symptoms. In fact, the consistent finding of a significant decrease of ICC, enteric neurons, and (especially) EGC, variously associated each other, justifies the abnormal motor behavior of the large bowel in these patients.

In fact, looking at the physiological properties of these cell populations, it is obvious that the disruption of their number/connections/relationship leads to an impairment of the complex regulation of the well-coordinated colonic motor patterns[64], thus affecting the viscus’ motility, due to the strict interplay between ICC, enteric neurons and EGC, with the latter acting as a physiologic bridge (not only by a simple mechanic point of view, but also by means of their neurotransmitter, immunologic, and trophic properties[65]) between the other two cell types.

Unfortunately, to date data are lacking on the possible factors causing neurenteric abnormalities in constipated patients. The current hypothesized mechanisms (often originating from experimental animal models) imply abnormalities in glial trophic factors leading to neural degeneration, and enteric localization of infective agents (bacteria, virus, prions) causing more or less selective degeneration of specific neurenteric cell populations (particularly EGC)[66], whereas genetic factors[67] or neurodegenerative changes due to aging seem to play a lesser role[68].

NEW CELLULAR PLAYERS IN NEUROMOTILITY DISORDERS

In biological sciences, interstitial tissue is seen as the connective tissue that surrounds the cells of a certain tissue while the extracellular matrix elements are known for its great capacity to retain water. However, except for a few described interstitial diseases (e.g., inflammatory bowel disease, interstitial cystitis, tubulointerstitial nephropathy, interstitial lung disease) its role is easily overlooked, as well as the significance of its cellular elements. Recent studies related to biological and histological data revealed, among the known resident (fibroblasts/fibrocytes, adipose cells) and non-resident cells (mast cells, plasma cells, eosinophils, macrophages, etc.) of interstitial space, a novel cell type-the telocyte[69,70].

Morphologically, telocytes represent interstitial cells with telopodes-the longest cellular extensions described besides the axons of neurons[71]. This rather unique cell type, difficult to visualize by routine microscopy, displays a particular morphology by electron microscopy: (1) a small cell body (9-15 μm) with scarce cytoplasmic organelles surrounding a moderately euchromatic nucleus; and (2) telopodes are usually tortuous and organized in a 3D network by overlapping and/or by homocellular interactions[72,73]. Telopodes are very long (10-1000 μm), thin (0.1 ± 0.5 μm) and moniliform cytoplasmic extensions; the moniliform aspect is created by the alternation of thin segments-podomers with dilated segments-podoms; the latter accomodate functional units consisting of caveolae, mitocondria and endoplasmic reticulum[74] and occupy a strategic position in relation to stem cell niches, blood capillaries, and/or nerve bundles[75,76]. Telopodes also establish stromal contacts with other cells, such as mast cells, basophils, lymphocytes, eosinophils, plasma cells, or macrophages[77] and non-cellular elements (e.g., collagen and elastic fibers)[78,79].

Telocytes have been described in human and mammalian cavitary and parenchymatous organs, as well as in serous membranes and other tissues (for details see http://www.telocytes.com). In the last two years telocytes were also described in the gut[77,80,81].

In modern times the significance of the information that could be achieved by signaling molecules found in intercellular fluids is overlooked. There is scarce information on the usefulness of the extracellular organelles (exosomes and shedding microvesicles) released in the extracellular space as mediators of cell-to-cell communication[82]. Such vesicles were recently demonstrated in the proximity of telopodes and even emerging from them in heart[83], lungs[76], skeletal muscle[76], pancreas[73], parotid gland[84] and human uterus[74].

Telocytes are supposed to be involved: (1) in intercellular signaling[72,74,77]; (2) as stem cell adjutants involved in tissue renewal[79,85]; (3) as sensors for steroid hormones[86]; (4) in the guidance of immune cells[77]; (5) as stretch sensors[87]; and (6) as contractility modulators[88]. Even though telocytes seem to be implicated in many important physiological and pathological processes[89,90], their exact functions still remain controversial. Although telocytes have not yet been described at colonic level, their possible involvement in pathophysiological mechanisms of chronic constipation cannot be overlooked. In favor of this hypothesis there is a possible correlation between the fact that telocytes express receptors for estrogen and progesterone[91,92] and the fact that chronic constipation is linked to sex hormones[93] and is higher in women of reproductive age[94].

CONCLUSION

The improvement of scientific knowledge and the constant, increasing ability to recognize previously unknown pathophysiologic mechanisms is of paramount importance. Thus, labels such as “idiopathic” or “functional”, that basically conceal the fact that too little is known of a specific pathologic entity[10], should be hopefully replaced when more knowledge is available, as pointed out several years ago[95]. As such, the recent recognition of neurenteric abnormalities in many patients complaining of constipation should point to reconsidering at least some of these forms (especially STC) as true enteric neuropathies, and to drop the “idiopathic”/“functional” label.

Besides semantic considerations, we feel that a better understanding of possible basic abnormalities in these patients is important, and may have therapeutic implications, addressing the researchers’ interest for new options toward more targeted approaches[16].

Footnotes

P- Reviewer Grundmann O S- Editor Wen LL L- Editor A E- Editor Zhang DN

References
1.  Grundy D. The changing face of gastrointestinal motility. Neurogastroenterol Motil. 1993;5:231-232.  [PubMed]  [DOI]
2.  McCrea GL, Miaskowski C, Stotts NA, Macera L, Paul SM, Varma MG. Gender differences in self-reported constipation characteristics, symptoms, and bowel and dietary habits among patients attending a specialty clinic for constipation. Gend Med. 2009;6:259-271.  [PubMed]  [DOI]
3.  Bassotti G, De Giorgio R, Stanghellini V, Tonini M, Barbara G, Salvioli B, Fiorella S, Corinaldesi R. Constipation: a common problem in patients with neurological abnormalities. Ital J Gastroenterol Hepatol. 1998;30:542-548.  [PubMed]  [DOI]
4.  Bassotti G, Maggio D, Battaglia E, Giulietti O, Spinozzi F, Reboldi G, Serra AM, Emanuelli G, Chiarioni G. Manometric investigation of anorectal function in early and late stage Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2000;68:768-770.  [PubMed]  [DOI]
5.  Chatoor D, Emmnauel A. Constipation and evacuation disorders. Best Pract Res Clin Gastroenterol. 2009;23:517-530.  [PubMed]  [DOI]
6.  Suares NC, Ford AC. Prevalence of, and risk factors for, chronic idiopathic constipation in the community: systematic review and meta-analysis. Am J Gastroenterol. 2011;106:1582-1591; quiz 1581, 1592.  [PubMed]  [DOI]
7.  Tack J, Müller-Lissner S, Stanghellini V, Boeckxstaens G, Kamm MA, Simren M, Galmiche JP, Fried M. Diagnosis and treatment of chronic constipation--a European perspective. Neurogastroenterol Motil. 2011;23:697-710.  [PubMed]  [DOI]
8.  American College of Gastroenterology Chronic Constipation Task Force. An evidence-based approach to the management of chronic constipation in North America. Am J Gastroenterol. 2005;100 Suppl 1:S1-S4.  [PubMed]  [DOI]
9.  Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology. 2006;130:1480-1491.  [PubMed]  [DOI]
10.  Wingate DL. “Functional” should not be shorthand for “I don’t know” in dyspepsia. BMJ. 2002;324:364.  [PubMed]  [DOI]
11.  Walker MM, Warwick A, Ung C, Talley NJ. The role of eosinophils and mast cells in intestinal functional disease. Curr Gastroenterol Rep. 2011;13:323-330.  [PubMed]  [DOI]
12.  Wouters MM. New insight in the pathogenesis of functional gastrointestinal disorders: association between genetics and colonic transit. Neurogastroenterol Motil. 2011;23:893-897.  [PubMed]  [DOI]
13.  Törnblom H, Lindberg G, Nyberg B, Veress B. Full-thickness biopsy of the jejunum reveals inflammation and enteric neuropathy in irritable bowel syndrome. Gastroenterology. 2002;123:1972-1979.  [PubMed]  [DOI]
14.  Walker MM, Talley NJ, Prabhakar M, Pennaneac’h CJ, Aro P, Ronkainen J, Storskrubb T, Harmsen WS, Zinsmeister AR, Agreus L. Duodenal mastocytosis, eosinophilia and intraepithelial lymphocytosis as possible disease markers in the irritable bowel syndrome and functional dyspepsia. Aliment Pharmacol Ther. 2009;29:765-773.  [PubMed]  [DOI]
15.  Iantorno G, Cinquetti M, Mazzocchi A, Morelli A, Bassotti G. Audit of constipation in a gastroenterology referral center. Dig Dis Sci. 2007;52:317-320.  [PubMed]  [DOI]
16.  Bassotti G, Villanacci V. A practical approach to diagnosis and management of functional constipation in adults. Intern Emerg Med. 2013;8:275-282.  [PubMed]  [DOI]
17.  Zarate N, Spencer NJ. Chronic constipation: lessons from animal studies. Best Pract Res Clin Gastroenterol. 2011;25:59-71.  [PubMed]  [DOI]
18.  Scott SM, van den Berg MM, Benninga MA. Rectal sensorimotor dysfunction in constipation. Best Pract Res Clin Gastroenterol. 2011;25:103-118.  [PubMed]  [DOI]
19.  Dinning PG, Di Lorenzo C. Colonic dysmotility in constipation. Best Pract Res Clin Gastroenterol. 2011;25:89-101.  [PubMed]  [DOI]
20.  Bassotti G, de Roberto G, Sediari L, Morelli A. Colonic motility studies in severe chronic constipation: an organic approach to a functional problem. Tech Coloproctol. 2004;8:147-150.  [PubMed]  [DOI]
21.  Bassotti G, de Roberto G, Castellani D, Sediari L, Morelli A. Normal aspects of colorectal motility and abnormalities in slow transit constipation. World J Gastroenterol. 2005;11:2691-2696.  [PubMed]  [DOI]
22.  Bassotti G, Chistolini F, Sietchiping-Nzepa F, de Roberto G, Morelli A, Chiarioni G. Biofeedback for pelvic floor dysfunction in constipation. BMJ. 2004;328:393-396.  [PubMed]  [DOI]
23.  Bassotti G, Chiarioni G, Germani U, Battaglia E, Vantini I, Morelli A. Endoluminal instillation of bisacodyl in patients with severe (slow transit type) constipation is useful to test residual colonic propulsive activity. Digestion. 1999;60:69-73.  [PubMed]  [DOI]
24.  Bouras EP, Camilleri M, Burton DD, Thomforde G, McKinzie S, Zinsmeister AR. Prucalopride accelerates gastrointestinal and colonic transit in patients with constipation without a rectal evacuation disorder. Gastroenterology. 2001;120:354-360.  [PubMed]  [DOI]
25.  Leung L, Riutta T, Kotecha J, Rosser W. Chronic constipation: an evidence-based review. J Am Board Fam Med. 2011;24:436-451.  [PubMed]  [DOI]
26.  Bassotti G, Villanacci V. Slow transit constipation: a functional disorder becomes an enteric neuropathy. World J Gastroenterol. 2006;12:4609-4613.  [PubMed]  [DOI]
27.  Knowles CH, Farrugia G. Gastrointestinal neuromuscular pathology in chronic constipation. Best Pract Res Clin Gastroenterol. 2011;25:43-57.  [PubMed]  [DOI]
28.  Bassotti G, Villanacci V, Rostami Nejad M. Chronic constipation: no more idiopathic, but a true neuropathological entity. GHFBB. 2011;4:109-115.  [PubMed]  [DOI]
29.  Wood JD. Enteric nervous system: sensory physiology, diarrhea and constipation. Curr Opin Gastroenterol. 2010;26:102-108.  [PubMed]  [DOI]
30.  Koch TR, Carney JA, Go L, Go VL. Idiopathic chronic constipation is associated with decreased colonic vasoactive intestinal peptide. Gastroenterology. 1988;94:300-310.  [PubMed]  [DOI]
31.  Cortesini C, Cianchi F, Infantino A, Lise M. Nitric oxide synthase and VIP distribution in enteric nervous system in idiopathic chronic constipation. Dig Dis Sci. 1995;40:2450-2455.  [PubMed]  [DOI]
32.  Webster M, Correa-Oliveira R, Gazzinelli G, Viana IR, Fraga LA, Silveira AM, Dunne DW. Factors affecting high and low human IgE responses to schistosome worm antigens in an area of Brazil endemic for Schistosoma mansoni and hookworm. Am J Trop Med Hyg. 1997;57:487-494.  [PubMed]  [DOI]
33.  Faussone-Pellegrini MS, Infantino A, Matini P, Masin A, Mayer B, Lise M. Neuronal anomalies and normal muscle morphology at the hypomotile ileocecocolonic region of patients affected by idiopathic chronic constipation. Histol Histopathol. 1999;14:1119-1134.  [PubMed]  [DOI]
34.  Zhao RH, Baig MK, Mack J, Abramson S, Woodhouse S, Wexner SD. Altered serotonin immunoreactivities in the left colon of patients with colonic inertia. Colorectal Dis. 2002;4:56-60.  [PubMed]  [DOI]
35.  Tomita R. Regulation of the peptidergic nerves (substance P and vasoactive intestinal peptide) in the colon of women patients with slow transit constipation: an in vitro study. Hepatogastroenterology. 2008;55:500-507.  [PubMed]  [DOI]
36.  Liu L, Shang F, Morgan MJ, King DW, Lubowski DZ, Burcher E. Cyclooxygenase-dependent alterations in substance P-mediated contractility and tachykinin NK1 receptor expression in the colonic circular muscle of patients with slow transit constipation. J Pharmacol Exp Ther. 2009;329:282-289.  [PubMed]  [DOI]
37.  Tzavella K, Riepl RL, Klauser AG, Voderholzer WA, Schindlbeck NE, Müller-Lissner SA. Decreased substance P levels in rectal biopsies from patients with slow transit constipation. Eur J Gastroenterol Hepatol. 1996;8:1207-1211.  [PubMed]  [DOI]
38.  Porter AJ, Wattchow DA, Hunter A, Costa M. Abnormalities of nerve fibers in the circular muscle of patients with slow transit constipation. Int J Colorectal Dis. 1998;13:208-216.  [PubMed]  [DOI]
39.  Menzies JR, McKee R, Corbett AD. Differential alterations in tachykinin NK2 receptors in isolated colonic circular smooth muscle in inflammatory bowel disease and idiopathic chronic constipation. Regul Pept. 2001;99:151-156.  [PubMed]  [DOI]
40.  Mitolo-Chieppa D, Mansi G, Nacci C, De Salvia MA, Montagnani M, Potenza MA, Rinaldi R, Lerro G, Siro-Brigiani G, Mitolo CI. Idiopathic chronic constipation: tachykinins as cotransmitters in colonic contraction. Eur J Clin Invest. 2001;31:349-355.  [PubMed]  [DOI]
41.  Tomita R, Tanjoh K, Fujisaki S, Ikeda T, Fukuzawa M. Regulation of the enteric nervous system in the colon of patients with slow transit constipation. Hepatogastroenterology. 2002;49:1540-1544.  [PubMed]  [DOI]
42.  Mitolo-Chieppa D, Mansi G, Rinaldi R, Montagnani M, Potenza MA, Genualdo M, Serio M, Mitolo CI, Rinaldi M, Altomare DF. Cholinergic stimulation and nonadrenergic, noncholinergic relaxation of human colonic circular muscle in idiopathic chronic constipation. Dig Dis Sci. 1998;43:2719-2726.  [PubMed]  [DOI]
43.  Tomita R, Fujisaki S, Ikeda T, Fukuzawa M. Role of nitric oxide in the colon of patients with slow-transit constipation. Dis Colon Rectum. 2002;45:593-600.  [PubMed]  [DOI]
44.  Tomita R, Igarashi S, Fujisaki S, Tanjoh K. The effects of neurotensin in the colon of patients with slow transit constipation. Hepatogastroenterology. 2007;54:1662-1666.  [PubMed]  [DOI]
45.  Wattchow D, Brookes S, Murphy E, Carbone S, de Fontgalland D, Costa M. Regional variation in the neurochemical coding of the myenteric plexus of the human colon and changes in patients with slow transit constipation. Neurogastroenterol Motil. 2008;20:1298-1305.  [PubMed]  [DOI]
46.  Krishnamurthy S, Schuffler MD, Rohrmann CA, Pope CE. Severe idiopathic constipation is associated with a distinctive abnormality of the colonic myenteric plexus. Gastroenterology. 1985;88:26-34.  [PubMed]  [DOI]
47.  Schouten WR, ten Kate FJ, de Graaf EJ, Gilberts EC, Simons JL, Klück P. Visceral neuropathy in slow transit constipation: an immunohistochemical investigation with monoclonal antibodies against neurofilament. Dis Colon Rectum. 1993;36:1112-1117.  [PubMed]  [DOI]
48.  Wedel T, Roblick UJ, Ott V, Eggers R, Schiedeck TH, Krammer HJ, Bruch HP. Oligoneuronal hypoganglionosis in patients with idiopathic slow-transit constipation. Dis Colon Rectum. 2002;45:54-62.  [PubMed]  [DOI]
49.  Meier-Ruge WA, Bruder E. Pathology of chronic constipation in pediatric and adult coloproctology. Pathobiology. 2005;72:1-102.  [PubMed]  [DOI]
50.  Bassotti G, Villanacci V, Salerni B, Maurer CA, Cathomas G. Beyond hematoxylin and eosin: the importance of immunohistochemical techniques for evaluating surgically resected constipated patients. Tech Coloproctol. 2011;15:371-375.  [PubMed]  [DOI]
51.  Wedel T, Spiegler J, Soellner S, Roblick UJ, Schiedeck TH, Bruch HP, Krammer HJ. Enteric nerves and interstitial cells of Cajal are altered in patients with slow-transit constipation and megacolon. Gastroenterology. 2002;123:1459-1467.  [PubMed]  [DOI]
52.  Lyford GL, He CL, Soffer E, Hull TL, Strong SA, Senagore AJ, Burgart LJ, Young-Fadok T, Szurszewski JH, Farrugia G. Pan-colonic decrease in interstitial cells of Cajal in patients with slow transit constipation. Gut. 2002;51:496-501.  [PubMed]  [DOI]
53.  Shafik A, Shafik AA, El-Sibai O, Shafik IA. Interstitial cells of cajal in patients with constipation due to total colonic inertia. J Invest Surg. 2006;19:147-153.  [PubMed]  [DOI]
54.  Yu CS, Kim HC, Hong HK, Chung DH, Kim HJ, Kang GH, Kim JC. Evaluation of myenteric ganglion cells and interstitial cells of Cajal in patients with chronic idiopathic constipation. Int J Colorectal Dis. 2002;17:253-258.  [PubMed]  [DOI]
55.  Lee JI, Park H, Kamm MA, Talbot IC. Decreased density of interstitial cells of Cajal and neuronal cells in patients with slow-transit constipation and acquired megacolon. J Gastroenterol Hepatol. 2005;20:1292-1298.  [PubMed]  [DOI]
56.  Bassotti G, Villanacci V, Maurer CA, Fisogni S, Di Fabio F, Cadei M, Morelli A, Panagiotis T, Cathomas G, Salerni B. The role of glial cells and apoptosis of enteric neurones in the neuropathology of intractable slow transit constipation. Gut. 2006;55:41-46.  [PubMed]  [DOI]
57.  Bassotti G, Villanacci V, Nascimbeni R, Asteria CR, Fisogni S, Nesi G, Legrenzi L, Mariano M, Tonelli F, Morelli A. Colonic neuropathological aspects in patients with intractable constipation due to obstructed defecation. Mod Pathol. 2007;20:367-374.  [PubMed]  [DOI]
58.  Tong WD, Liu BH, Zhang LY, Xiong RP, Liu P, Zhang SB. Expression of c-kit messenger ribonucleic acid and c-kit protein in sigmoid colon of patients with slow transit constipation. Int J Colorectal Dis. 2005;20:363-367.  [PubMed]  [DOI]
59.  Park HJ, Kamm MA, Abbasi AM, Talbot IC. Immunohistochemical study of the colonic muscle and innervation in idiopathic chronic constipation. Dis Colon Rectum. 1995;38:509-513.  [PubMed]  [DOI]
60.  Toman J, Turina M, Ray M, Petras RE, Stromberg AJ, Galandiuk S. Slow transit colon constipation is not related to the number of interstitial cells of Cajal. Int J Colorectal Dis. 2006;21:527-532.  [PubMed]  [DOI]
61.  Knowles CH, Nickols CD, Scott SM, Bennett NI, de Oliveira RB, Chimelli L, Feakins R, Williams NS, Martin JE. Smooth muscle inclusion bodies in slow transit constipation. J Pathol. 2001;193:390-397.  [PubMed]  [DOI]
62.  van den Berg MM, Di Lorenzo C, Mousa HM, Benninga MA, Boeckxstaens GE, Luquette M. Morphological changes of the enteric nervous system, interstitial cells of cajal, and smooth muscle in children with colonic motility disorders. J Pediatr Gastroenterol Nutr. 2009;48:22-29.  [PubMed]  [DOI]
63.  Wedel T, Van Eys GJ, Waltregny D, Glénisson W, Castronovo V, Vanderwinden JM. Novel smooth muscle markers reveal abnormalities of the intestinal musculature in severe colorectal motility disorders. Neurogastroenterol Motil. 2006;18:526-538.  [PubMed]  [DOI]
64.  Narducci F, Bassotti G, Gaburri M, Morelli A. Twenty four hour manometric recording of colonic motor activity in healthy man. Gut. 1987;28:17-25.  [PubMed]  [DOI]
65.  Bassotti G, Villanacci V, Antonelli E, Morelli A, Salerni B. Enteric glial cells: new players in gastrointestinal motility. Lab Invest. 2007;87:628-632.  [PubMed]  [DOI]
66.  Bassotti G, Villanacci V. Can “functional” constipation be considered as a form of enteric neuro-gliopathy. Glia. 2011;59:345-350.  [PubMed]  [DOI]
67.  Rossi E, Villanacci V, Fisogni S, Morelli A, Salerni B, Grigolato P, Bassotti G. Chromosomal study of enteric glial cells and neurons by fluorescence in situ hybridization in slow transit constipation. Neurogastroenterol Motil. 2007;19:578-584.  [PubMed]  [DOI]
68.  Bassotti G, Villanacci V, Fisogni S, Cadei M, Di Fabio F, Salerni B. Apoptotic phenomena are not a major cause of enteric neuronal loss in constipated patients with dementia. Neuropathology. 2007;27:67-72.  [PubMed]  [DOI]
69.  Popescu LM, Faussone-Pellegrini MS. TELOCYTES - a case of serendipity: the winding way from Interstitial Cells of Cajal (ICC), via Interstitial Cajal-Like Cells (ICLC) to TELOCYTES. J Cell Mol Med. 2010;14:729-740.  [PubMed]  [DOI]
70.  Popescu LM. Telocytes-a novel type of interstitial cells. Recent researches in modern medicine-HISTEM'11. Cambridge: WSEAS Press 2011; 424-432.  [PubMed]  [DOI]
71.  Faussone-Pellegrini M, Popescu LM. Telocytes. Biomolecular Concepts. 2011;2:481-489.  [PubMed]  [DOI]
72.  Gherghiceanu M, Popescu LM. Cardiac telocytes - their junctions and functional implications. Cell Tissue Res. 2012;348:265-279.  [PubMed]  [DOI]
73.  Nicolescu MI, Popescu LM. Telocytes in the interstitium of human exocrine pancreas: ultrastructural evidence. Pancreas. 2012;41:949-956.  [PubMed]  [DOI]
74.  Creţoiu SM, Creţoiu D, Popescu LM. Human myometrium - the ultrastructural 3D network of telocytes. J Cell Mol Med. 2012;16:2844-2849.  [PubMed]  [DOI]
75.  Popescu LM, Gherghiceanu M, Suciu LC, Manole CG, Hinescu ME. Telocytes and putative stem cells in the lungs: electron microscopy, electron tomography and laser scanning microscopy. Cell Tissue Res. 2011;345:391-403.  [PubMed]  [DOI]
76.  Popescu LM, Manole E, Serboiu CS, Manole CG, Suciu LC, Gherghiceanu M, Popescu BO. Identification of telocytes in skeletal muscle interstitium: implication for muscle regeneration. J Cell Mol Med. 2011;15:1379-1392.  [PubMed]  [DOI]
77.  Cretoiu D, Cretoiu SM, Simionescu AA, Popescu LM. Telocytes, a distinct type of cell among the stromal cells present in the lamina propria of jejunum. Histol Histopathol. 2012;27:1067-1078.  [PubMed]  [DOI]
78.  Rusu MC, Mirancea N, Mănoiu VS, Vâlcu M, Nicolescu MI, Păduraru D. Skin telocytes. Ann Anat. 2012;194:359-367.  [PubMed]  [DOI]
79.  Ceafalan L, Gherghiceanu M, Popescu LM, Simionescu O. Telocytes in human skin--are they involved in skin regeneration. J Cell Mol Med. 2012;16:1405-1420.  [PubMed]  [DOI]
80.  Cantarero Carmona I, Luesma Bartolomé MJ, Junquera Escribano C. Identification of telocytes in the lamina propria of rat duodenum: transmission electron microscopy. J Cell Mol Med. 2011;15:26-30.  [PubMed]  [DOI]
81.  Rusu MC, Nicolescu MI, Jianu AM, Lighezan R, Mănoiu VS, Păduraru D. Esophageal telocytes and hybrid morphologies. Cell Biol Int. 2012;36:1079-1088.  [PubMed]  [DOI]
82.  Ludwig AK, Giebel B. Exosomes: small vesicles participating in intercellular communication. Int J Biochem Cell Biol. 2012;44:11-15.  [PubMed]  [DOI]
83.  Manole CG, Cismaşiu V, Gherghiceanu M, Popescu LM. Experimental acute myocardial infarction: telocytes involvement in neo-angiogenesis. J Cell Mol Med. 2011;15:2284-2296.  [PubMed]  [DOI]
84.  Nicolescu MI, Bucur A, Dinca O, Rusu MC, Popescu LM. Telocytes in parotid glands. Anat Rec (Hoboken). 2012;295:378-385.  [PubMed]  [DOI]
85.  Popescu BO, Gherghiceanu M, Kostin S, Ceafalan L, Popescu LM. Telocytes in meninges and choroid plexus. Neurosci Lett. 2012;516:265-269.  [PubMed]  [DOI]
86.  Cretoiu SM, Cretoiu D, Simionescu A, Popescu LM.  Telocytes in Human Fallopian Tube and Uterus Express Estrogen and Progesterone Receptors. In: Kahn SM. Sex Steroids 2012; (Ed) Available from: http://www.intechopen.com/books/sexsteroids/telocytes-in-human-fallopian-tube-and-uterus-express-estrogen-and-progesterone-receptors.  [PubMed]  [DOI]
87.  Hutchings G, Williams O, Cretoiu D, Ciontea SM. Myometrial interstitial cells and the coordination of myometrial contractility. J Cell Mol Med. 2009;13:4268-4282.  [PubMed]  [DOI]
88.  Cretoiu SM, Simionescu AA, Caravia L, Curici A, Cretoiu D, Popescu LM. Complex effects of imatinib on spontaneous and oxytocin-induced contractions in human non-pregnant myometrium. Acta Physiol Hung. 2011;98:329-338.  [PubMed]  [DOI]
89.  Ardeleanu C, Bussolati G. Telocytes are the common cell of origin of both PEComas and GISTs: an evidence-supported hypothesis. J Cell Mol Med. 2011;15:2569-2574.  [PubMed]  [DOI]
90.  Zheng Y, Bai C, Wang X. Potential significance of telocytes in the pathogenesis of lung diseases. Expert Rev Respir Med. 2012;6:45-49.  [PubMed]  [DOI]
91.  Cretoiu SM, Cretoiu D, Suciu L, Popescu LM. Interstitial Cajal-like cells of human Fallopian tube express estrogen and progesterone receptors. J Mol Histol. 2009;40:387-394.  [PubMed]  [DOI]
92.  Gevaert T, De Vos R, Van Der Aa F, Joniau S, van den Oord J, Roskams T, De Ridder D. Identification of telocytes in the upper lamina propria of the human urinary tract. J Cell Mol Med. 2012;16:2085-2093.  [PubMed]  [DOI]
93.  Leung FW. Etiologic factors of chronic constipation: review of the scientific evidence. Dig Dis Sci. 2007;52:313-316.  [PubMed]  [DOI]
94.  Beckett EA, McCloskey C, O’Kane N, Sanders KM, Koh SD. Effects of female steroid hormones on A-type K+ currents in murine colon. J Physiol. 2006;573:453-468.  [PubMed]  [DOI]
95.  Snape WJ. Taking the idiopathic out of intestinal pseudo-obstruction. Ann Intern Med. 1981;95:646-647.  [PubMed]  [DOI]